29
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

Supraphysiological doses of glucocorticoids induce remission in a patient with retroperitoneal fibrosis but no effect on the course of Hashimoto’s thyroiditis: a discordant mode of action

, ORCID Icon, &
Pages 172-178 | Received 01 Feb 2019, Accepted 20 May 2019, Published online: 18 Jun 2019

Reference

  • Kim BS, Lee WK, Choi HM, et al. Idiopathic retroperitoneal fibrosis associated with Hashimoto’s thyroiditis in a patient with a single functioning kidney. Kidney Res Clin Pract. 2013;32:183–185.
  • Lee JE, Han SH, Kim DK, et al. Idiopathic retroperitoneal fibrosis associated with Hasimoto’s thyroiditis in an old-aged man. Yonsei Med J. 2008;49:1032–1035.
  • Swartz RD. Idiopathic retroperitoneal fibrosis: a review of the pathogenesis and approaches to treatment. Am J Kidney Dis. 2009;54:546–553.
  • Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13:391–397.
  • Brent GA, Weetman AP. Hypothyroidism and thyroiditis. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, editors. Williams textbook of endocrinology. Philadelphia (PA): Elsevier; 2016. p. 416–448.
  • Arata N, Ando T, Unger P, et al. By-stander activation in autoimmune thyroiditis: studies on experimental autoimmune thyroiditis in the GFP + fluorescent mouse. Clin Immunol. 2006;121:108–117.
  • Heufelder AE, Wenzel BE, Gorman CA, et al. Detection, cellular localization, and modulation of heat shock proteins in cultured fibroblasts from patients with extrathyroidal manifestations of Graves’ disease. J Clin Endocrinol Metab. 1991;73:739–745.
  • Ishihara T, Mori T, Waseda N, et al. Histological, clinical and laboratory findings of acute exacerbation of Hashimoto’s thyroiditis-comparison with those of subacute granulomatous thyroiditis. Endocrinol Jpn. 1987;34:831–841.
  • Mazza E, Quaglino F, Suriani A, et al. Thyroidectomy for painful thyroiditis resistant to steroid treatment: three new cases with review of the literature. Case Rep Endocrinol. 2015;2015:138327.
  • Zimmerman RS, Brennan MD, McConahey WM, et al. Hashimoto’s thyroiditis. An uncommon cause of painful thyroid unresponsive to corticosteroid therapy. Ann Intern Med. 1986;104:355–357.
  • Gourgiotis L, Al-Zubaidi N, Skarulis MC, et al. Successful outcome after surgical management in two cases of the “painful variant” of Hashimoto’s thyroiditis. Endocr Pract. 2002;8:259–265.
  • Kon YC, DeGroot LJ. Painful Hashimoto’s thyroiditis an indication for thyroidectomy: clinical characteristics and outcome in seven patients. J Clin Endocrinol Metab. 2003;88:2667–2672.
  • Ohye H, Fukata S, Kubota S, et al. Successful treatment for recurrent painful Hashimoto’s thyroiditis by total thyroidectomy. Thyroid. 2005;15:340–345.
  • Rotondi M, Capelli V, Locantore P, et al. Painful Hashimoto’s thyroiditis: myth or reality? J Endocrinol Invest. 2017;40:815–818.
  • Blizzard RM, Hung W, Chandler RW, et al. Hashimoto’s thyroiditis: clinical and laboratory responses to prolonged cortisone therapy. N Engl J Med. 1962;267:1015–1020.
  • Nicoloff JT, Fisher DA, Appleman MD Jr. The role of glucocorticoids in the regulation of thyroid function in man. J Clin Invest. 1970;49:1922–1929.
  • Karantanis D, Bogsrud TV, Wiseman GA, et al. Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland. J Nucl Med. 2007;48:896–901.
  • Yasuda S, Shohtsu A, Ide M, et al. Chronic thyroiditis: diffuse uptake of FDG at PET. Radiology. 1998;207:775–778.
  • Edo N, Morita K, Sakamoto M, et al. Correlation between anti-thyroid peroxidase antibody levels and diffuse thyroid uptake of 18F-fluorodexoyglucose in Hashimoto’s thyroiditis: a retrospective study. Thyroid Res. 2018;11:1–5.
  • Katz SM, Vickery AL Jr. The fibrous variant of Hashimoto’s thyroiditis. Hum Pathol. 1974;5:161–170.
  • Neild GH, Rodriguez-Justo M, Wall C, et al. Hyper-IgG4 disease: report and characterisation of a new disease. BMC Med. 2006;4:23–41.
  • Harach HR, Williams ED. Characterization of plasma cell subsets in thyroid disease. Medicina (B Aires). 1985;45:522–524.
  • Li Y, Nishihara E, Hirokawa M, et al. Distinct clinical, serological, and sonographic characteristics of Hashimoto’s thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab. 2010;95:1309–1317.
  • Li Y, Nishihara E, Kakudo K. Hashimoto’s thyroiditis: old concepts and new insights. Curr Opin Rheumatol. 2011;23:102–107.
  • Li Y, Zhou G, Ozaki T, et al. Distinct histopathological features of Hashimoto’s thyroiditis with respect to IgG4-related disease. Mod Pathol. 2012;25:1086–1097.
  • Fernado A, Pattison J, Horsfield C, et al. [18F]-Fluorodeoxyglucose positron emission tomography in the diagnosis, treatment stratification, and monitoring of patients with retroperitoneal fibrosis: a prospective clinical study. Eur Urol. 2017;71:926–933.
  • Ceresini G, Urban ML, Corradi D, et al. Association between idiopathic retroperitoneal fibrosis and autoimmune thyroiditis: a case-control study. Autoimmun Rev. 2015;14:16–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.